EXPERIMENTAL DATA FOR THE USE OF RIFAMYCIN SV IN BILIARY TRACT INFECTIONS: IN VITRO ACTIVITY AGAINST VARIOUS PATHOGENIC BACTERIA AND BILE CONCENTRATIONS IN MAN.
D000900:Anti-Bacterial Agents; D001419:Bacteria; D001646:Bile; D001659:Biliary Tract; D002701:Chloramphenicol; D002761:Cholangitis; D002764:Cholecystitis; D004754:Enterobacter; D004927:Escherichia coli Infections; D006505:Hepatitis; D066298:In Vitro Techniques; D007239:Infections; D010406:Penicillins; D011512:Proteus Infections; D012294:Rifamycins; D013307:Streptomycin; D013752:Tetracycline
D000900:Anti-Bacterial Agents; D010406:Penicillins; D012294:Rifamycins; D002701:Chloramphenicol; C023808:rifamycin SV; D013752:Tetracycline; D013307:Streptomycin
AEROBACTER; CHLORAMPHENICOL; CHOLANGITIS; CHOLECYSTITIS; ESCHERICHIA COLI INFECTIONS; HEPATITIS; INFECTION; PENICILLIN; PROTEUS INFECTIONS; RIFOMYCIN; STREPTOMYCIN; TETRACYCLINE